Literature DB >> 24668037

Rapid antidepressant effects and abuse liability of ketamine.

Chun Yang1, Kenji Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24668037     DOI： 10.1007/s00213-014-3543-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  9 in total

1.  Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice.

Authors:  T Suzuki; T Aoki; H Kato; M Yamazaki; M Misawa
Journal:  Eur J Pharmacol       Date:  1999-12-03       Impact factor: 4.432

2.  The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.

Authors:  Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

3.  R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.

Authors:  Ji-Chun Zhang; Su-Xia Li; Kenji Hashimoto
Journal:  Pharmacol Biochem Behav       Date:  2013-12-03       Impact factor: 3.533

Review 4.  Ketamine use: a review.

Authors:  Celia J A Morgan; H Valerie Curran
Journal:  Addiction       Date:  2011-07-22       Impact factor: 6.526

5.  Taming the ketamine tiger. 1965.

Authors:  Edward F Domino
Journal:  Anesthesiology       Date:  2010-09       Impact factor: 7.892

6.  Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

Review 7.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

Authors:  Kenji Hashimoto; Berend Malchow; Peter Falkai; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-01       Impact factor: 5.270

Review 8.  Ketamine and the next generation of antidepressants with a rapid onset of action.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy Diazgranados; Carlos A Zarate
Journal:  Pharmacol Ther       Date:  2009-05-03       Impact factor: 12.310

Review 9.  Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Authors:  John H Krystal; Gerard Sanacora; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382
  9 in total
  21 in total

Review 1.  Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Authors:  Gerard Sanacora; Alan F Schatzberg
Journal:  Neuropsychopharmacology       Date:  2014-09-26       Impact factor: 7.853

2.  Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.

Authors:  Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2014-09-05       Impact factor: 4.530

3.  Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression.

Authors:  Yukihiko Shirayama; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-01       Impact factor: 5.270

4.  Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.

Authors:  Ji-chun Zhang; Wei Yao; Chao Dong; Chun Yang; Qian Ren; Min Ma; Mei Han; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2015-09-04       Impact factor: 4.530

5.  Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats.

Authors:  Kristin J Schoepfer; Caroline E Strong; Samantha K Saland; Katherine N Wright; Mohamed Kabbaj
Journal:  Physiol Behav       Date:  2017-10-18

6.  Effects of subanesthetic ketamine and (2R,6R) hydroxynorketamine on working memory and synaptic transmission in the nucleus reuniens in mice.

Authors:  Priyodarshan Goswamee; Remington Rice; Elizabeth Leggett; Fan Zhang; Sofia Manicka; Joseph H Porter; A Rory McQuiston
Journal:  Neuropharmacology       Date:  2022-01-20       Impact factor: 5.250

Review 7.  Inflammatory biomarkers as differential predictors of antidepressant response.

Authors:  Kenji Hashimoto
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

8.  Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model.

Authors:  H-L Sun; Z-Q Zhou; G-F Zhang; C Yang; X-M Wang; J-C Shen; K Hashimoto; J-J Yang
Journal:  Transl Psychiatry       Date:  2016-02-23       Impact factor: 6.222

9.  Combination of Nitrous Oxide with Isoflurane or Scopolamine for Treatment-resistant Major Depression.

Authors:  Chun Yang; Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

10.  BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.

Authors:  Q Ren; M Ma; C Yang; J-C Zhang; W Yao; K Hashimoto
Journal:  Transl Psychiatry       Date:  2015-10-27       Impact factor: 6.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.